We are live on ! Find out more

OrthoPediatrics

KIDS

Market cap $570M

21.82 USD

+0.04

0.18%

At close Updated Sep 18, 4:00 PM EDT

Pre-market

After hours

21.82

0.00

0%

1 day

0.18%

5 days

-1.67%

1 month

-14.43%

3 months

15.63%

6 months

30.97%

Year to date

24.26%

1 year

8.5%

5 years

-67.11%

10 years

13.53%

About: OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.

Employees: 602

Healthcare Medical Devices

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 11.1%

Neutral 66.7%

Negative 22.2%

OrthoPediatrics Announces Full Commercial Launch of 3P™ Pediatric Plating Platform® Hip System Following More Than 350 Successful Implantations

Successful Limited Launch Demonstrates Demand for Innovative Pediatric-Specific Hip Plating Technology Successful Limited Launch Demonstrates Demand for Innovative Pediatric-Specific Hip Plating Technology

OrthoPediatrics Announces Full Commercial Launch of 3P™ Pediatric Plating Platform® Hip System Following More Than 350 Successful Implantations

OrthoPediatrics Sees ‘Inflection Point' as New Products Fuel Record Quarter

OrthoPediatrics NASDAQ: KIDS reported record revenue, adjusted EBITDA and number of children helped during the second quarter, as the pediatric orthopedic device company began to see early contributions from its newer “super cycle” products, Chief Executive Officer Dave Bailey said at the Canaccord Genuity Growth Conference.

OrthoPediatrics Sees ‘Inflection Point' as New Products Fuel Record Quarter

OrthoPediatrics Corp. (KIDS) Q2 2026 Earnings Call Transcript

OrthoPediatrics Corp. (KIDS) Q2 2026 Earnings Call Transcript

OrthoPediatrics Corp. (KIDS) Q2 2026 Earnings Call Transcript

OrthoPediatrics Q2 Earnings Call Highlights

OrthoPediatrics NASDAQ: KIDS reported record second-quarter revenue of $70.5 million, up 15% from a year earlier, as strong Trauma & Deformity and specialty bracing performance offset a reported decline in scoliosis revenue. The company also raised its 2026 revenue outlook while maintaining its adjusted EBITDA and free-cash-flow targets.

OrthoPediatrics Q2 Earnings Call Highlights

Zacks Investment Research

OrthoPediatrics (KIDS) Reports Q2 Loss, Tops Revenue Estimates

OrthoPediatrics (KIDS) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to a loss of $0.11 per share a year ago.

OrthoPediatrics (KIDS) Reports Q2 Loss, Tops Revenue Estimates

OrthoPediatrics Corp. Reports Second Quarter 2026 Financial Results and Increases 2026 Financial Guidance

WARSAW, Ind., Aug. 04, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the second quarter ended June 30, 2026.

OrthoPediatrics Corp. Reports Second Quarter 2026 Financial Results and Increases 2026 Financial Guidance

OrthoPediatrics to Participate in the Canaccord Genuity 46th Annual Growth Conference

WARSAW, Ind., July 29, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference, held in Boston, MA.

OrthoPediatrics to Participate in the Canaccord Genuity 46th Annual Growth Conference

OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 4, 2026

WARSAW, Ind., July 21, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its second quarter 2026 financial results on Tuesday, August 4, 2026 after the market closes. OrthoPediatrics will host a conference call on Tuesday, August 4, 2026 at 4:30 p.m. ET to discuss the results.

OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 4, 2026

OrthoPediatrics Announces Distribution Agreement with OSSIO, Inc. to Provide Revolutionary Orthopedic Fixation Technology to U.S. Children's Hospitals Nationwide

WARSAW, Ind., June 24, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced an exclusive distribution agreement with OSSIO, Inc. (“OSSIO”) that brings U.S. children's hospitals nationwide a bio-integrative, metal-free fixation technology ideally suited for treatment of fractures and deformities in pediatric patients.

OrthoPediatrics Announces Distribution Agreement with OSSIO, Inc. to Provide Revolutionary Orthopedic Fixation Technology to U.S. Children's Hospitals Nationwide

OrthoPediatrics Corp. (KIDS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

OrthoPediatrics Corp. (KIDS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

OrthoPediatrics Corp. (KIDS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

See News Rankings

Price charts implemented using Lightweight Charts™